UPDATE: Morgan Stanley Reiterates Overweight Rating, Removes PT on Walgreen Company as Inversion Debate Continues

In a report published Monday, Morgan Stanley analyst Ricky R. Goldwasser reiterated an Overweight rating on Walgreen Company WAG, but removed the $75.00 price target. In the report, Morgan Stanley noted, “Political debate intensifying around high profile tax inversion deals adding to the uncertainty around the plausibility of inversion for WAG. While prospects for inversion have been a key debate for WAG shares, we see opportunities for the combined WAG/AB to lower tax rate and expand margins independent of a corporate inversion.” Walgreen Company closed on Friday at $68.66.